phenobarbital has been researched along with dantrolene in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Francis, KT; Hamrick, ME | 1 |
Abernathy, CO; Ezekiel, M; Utili, R; Zimmerman, HJ | 1 |
Batt, AM; Goulon-Ginet, C; Jayyosi, Z; Livertoux, MH; Siest, G; Souhaili, H; Totis, M | 1 |
Born, CK; Francis, FT; Hamrick, ME; Roy, S | 1 |
Borowicz, KK; Czuczwar, SJ; Gasior, M; Kleinrok, Z | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for phenobarbital and dantrolene
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for phenobarbital and dantrolene
Article | Year |
---|---|
Dantrolene inhibition of the hepatic mixed function oxidase system.
Topics: Aminopyrine N-Demethylase; Animals; Cytochrome P-450 Enzyme System; Dantrolene; Ethylmorphine-N-Demethylase; Hexobarbital; Hydantoins; Kinetics; Liver; Male; Methylcholanthrene; Mixed Function Oxygenases; Oxidoreductases; Phenobarbital; Rats; Time Factors | 1979 |
The effects of dantrolene sodium on excretory function in the isolated perfused rat liver.
Topics: Animals; Aspartate Aminotransferases; Bile; Bile Acids and Salts; Dantrolene; Hydantoins; In Vitro Techniques; Liver; Male; Methylcholanthrene; Phenobarbital; Rats; Sulfobromophthalein | 1978 |
Induction of hepatic cytochrome P-450c-dependent monooxygenase activities by dantrolene in rat.
Topics: Animals; Cytochrome P-450 Enzyme System; Dantrolene; Enzyme Induction; Epoxide Hydrolases; Glucuronosyltransferase; Male; Methylcholanthrene; Microsomes, Liver; Oxygenases; Phenobarbital; Rats; Rats, Inbred Strains | 1987 |
Interaction of dantrolene with the hepatic mixed function oxidase system.
Topics: Animals; Cytochrome P-450 Enzyme System; Dantrolene; Liver; Male; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases; Phenobarbital; Proteins; Rats | 1980 |
Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Anticonvulsants; Calcium Channel Agonists; Calcium Channel Blockers; Carbamazepine; Dantrolene; Dihydropyridines; Disease Models, Animal; Drug Interactions; Electroshock; Epilepsy; Female; Isradipine; Lethal Dose 50; Mice; Motor Activity; Phenobarbital; Phenytoin; Random Allocation; Seizures; Valproic Acid | 1997 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |